Rheumatoid Arthritis Pocket Book


Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that results in significant functional disability due to progressive and widespread joint destruction and soft tissue damage, not only in the limbs but also the inflammatory processes can ultimately have an effect on most organ systems in the body, with devastating morbid consequences.
Therefore, appropriate management of RA needs to address not only the impact on joints, but also the whole body, the person suffering from the disease, their families and carers, and where appropriate their employers.

Drug Class & Related Drugs
Actemra tocilizumab class: interleukin inhibitors
Arava leflunomide class: antirheumatics, selective immunosuppressants
Azulfidine sulfasalazine class: 5-aminosalicylates, sulfonamides
Azulfidine EN-tabs sulfasalazine class: 5-aminosalicylates, sulfonamides
Celebrex celecoxib class: cox-2 inhibitors
Cimzia certolizumab class: TNF alfa inhibitors
Duexis famotidine/ibuprofen class: nonsteroidal anti-inflammatory agents
Enbrel etanercept class: antirheumatics, TNF alfa inhibitors
Humira adalimumab class: antirheumatics, TNF alfa inhibitors
Kineret anakinra class: antirheumatics, interleukin inhibitors
Mobic meloxicam class: nonsteroidal anti-inflammatory agents
Norco acetaminophen/hydrocodone class: narcotic analgesic combinations
Orencia abatacept class: antirheumatics, selective immunosuppressants
Plaquenil hydroxychloroquine class: antimalarial quinolines, antirheumatics
Remicade infliximab class: antirheumatics, TNF alfa inhibitors
Rituxan rituximab class: antirheumatics, CD20 monoclonal antibodies
Simponi golimumab class: TNF alfa inhibitors
Sulfazine sulfasalazine class: 5-aminosalicylates, sulfonamides
Vicodin acetaminophen/hydrocodone class: narcotic analgesic combinations
Vimovo esomeprazole/naproxen class: nonsteroidal anti-inflammatory agents